Pembrolizumab与多西紫杉醇在晚期经治PD-L1阳性非小细胞肺癌患者中的疗效比较
评价者:宋勇1, 文献合成者:张潮2

Compare the Curative Effect of Pembrolizumab and Docetaxel for Previously Treated PD-L1-Positive Advanced Non-Small Cell Lung Cancer
Reviewer:SONG Yong1, Literature Co-worker: ZHANG Chao2